Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin

Simple item page
dc.contributor.authorAubry, C.
dc.contributor.authorWilson, A. J.
dc.contributor.authorJenkins, Paul R.
dc.contributor.authorMahale, S.
dc.contributor.authorChaudhuri, B.
dc.contributor.authorMaréchal, Jean-Didier
dc.contributor.authorSutcliffe, Michael J.
dc.date.accessioned2009-11-06T14:24:40Z
dc.date.available2009-11-06T14:24:40Z
dc.date.issued2006
dc.identifier.citationAubry C., Wilson A. J., Jenkins P. R.,Mahale S., Chaudhuri B., Marechal J-D. and Sutcliffe M. J. (2006) Design, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysin. Organic and Biomolecular Chemistry, 4, pp. 787-801en
dc.identifier.doihttps://doi.org/10.1039/b518019h
dc.identifier.urihttp://hdl.handle.net/2086/2800
dc.language.isoenen
dc.peerreviewedYesen
dc.publisherRoyal Society of Chemistryen
dc.researchgroupChemistry for Health
dc.titleDesign, synthesis and biological activity of new CDK4-specific inhibitors, based on fascaplysinen
dc.typeArticleen

Files

License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
3.25 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Leicester School of Pharmacy